Elevated levels of SRSF9 are associated with a negative prognosis in ovarian cancer, as SRSF9 promotes an increased transcriptional ratio of sirtuin 4 (SIRT4)/SIRT6. This evidence concerns the gene SIRT4 and ovarian cancer.